Bioresorbable vascular scaffold to treat in ‐stent restenosis: Single‐center experience

ConclusionsThese real‐world data using BVS in patients with ISR demonstrates that ISR treatment with ABSORB™ BVS is feasible but could have slightly higher target lesion failure rates as compared to DES. This proof of concept could be hypothesis‐generating for larger randomized controlled studies.

Source: Journal of Interventional Cardiology - August 7, 2017 Category: Cardiology Authors: Fabien Picard, Robert Avram, Guillaume Marquis ‐Gravel, Victor‐Xavier Tadros, Hung Q. Ly, Quentin de Hemptinne, Jean‐François Dorval, Philippe L. L'allier, Jean‐François Tanguay Tags: ORIGINAL INVESTIGATION Source Type: research